𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The use of molecular modeling in anticancer drug design

✍ Scribed by Stephen Neidle

Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
125 KB
Volume
7
Category
Article
ISSN
0263-7855

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The development of composite circulating
The development of composite circulating biomarker models for use in anticancer drug clinical development
✍ Lee J. Lancashire; Darren L. Roberts; Caroline Dive; Andrew G. Renehan πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 373 KB

## Abstract The development of informative composite circulating biomarkers predicting cancer presence or therapy response is clinically attractive but optimal approaches to modeling are as yet unclear. This study investigated multidimensional relationships within an example panel of serum insulin‐

Advances in molecular carcinogenesis: cu
Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs
✍ Anita F.W. Frijhoff; Claudio J. Conti; Adrian M. Senderowicz πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 183 KB

## Abstract Survival of patients with advanced solid tumors has not significantly improved over the past 30 years. Although molecularly targeted anticancer drugs offer promise, few drugs make it through the end of the Food and Drug Administration approval process. Animal models that more closely re